NCT03573206View on ClinicalTrials.gov

AMBULATE Continued Access Protocol to Evaluate the Cardiva Mid-Bore Venous Vascular Closure System (VVCS)

NACompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

August 27, 2018

Primary Completion Date

January 14, 2019

Study Completion Date

March 31, 2019

Conditions
Surgical Wound
Interventions
DEVICE

Cardiva Mid-Bore Venous Vascular Closure Device (VVCS)

The device will be used to close all femoral venous access sites at the end of the case.

Trial Locations (3)

30342

Emory St. Joseph's Hospital, Atlanta

78705

Texas Cardiac Arrhythmia Research Foundation, Austin

07450

Valley Hospital, Ridgewood

Sponsors
All Listed Sponsors
lead

Cardiva Medical, Inc.

INDUSTRY